WO2003057871A1 - Enzymes coated with ionic liquid - Google Patents

Enzymes coated with ionic liquid Download PDF

Info

Publication number
WO2003057871A1
WO2003057871A1 PCT/KR2003/000067 KR0300067W WO03057871A1 WO 2003057871 A1 WO2003057871 A1 WO 2003057871A1 KR 0300067 W KR0300067 W KR 0300067W WO 03057871 A1 WO03057871 A1 WO 03057871A1
Authority
WO
WIPO (PCT)
Prior art keywords
ionic liquid
lipase
coated
enzyme
group
Prior art date
Application number
PCT/KR2003/000067
Other languages
French (fr)
Inventor
Mahn-Joo Kim
Jae Kwan Lee
Original Assignee
Posco
Postech Foundation
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Posco, Postech Foundation filed Critical Posco
Priority to JP2003558171A priority Critical patent/JP2005514033A/en
Priority to US10/471,190 priority patent/US7005282B2/en
Priority to EP03701172A priority patent/EP1468083A1/en
Priority to CA002441430A priority patent/CA2441430A1/en
Publication of WO2003057871A1 publication Critical patent/WO2003057871A1/en

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12PFERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
    • C12P41/00Processes using enzymes or microorganisms to separate optical isomers from a racemic mixture
    • C12P41/003Processes using enzymes or microorganisms to separate optical isomers from a racemic mixture by ester formation, lactone formation or the inverse reactions
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/14Hydrolases (3)
    • C12N9/16Hydrolases (3) acting on ester bonds (3.1)
    • C12N9/18Carboxylic ester hydrolases (3.1.1)
    • C12N9/20Triglyceride splitting, e.g. by means of lipase
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/96Stabilising an enzyme by forming an adduct or a composition; Forming enzyme conjugates

Definitions

  • the present invention relates to an enzyme coated with an ionic liquid and more particularly, to the preparation and use of an enzyme coated with an ionic liquid, which shows better enantioselectivity than its uncoated counterpart and can be repeatedly reused with no significant loss in catalytic activities.
  • Enzymatic kinetic resolution of racemic substrates using hydrolytic enzymes provides a useful methodology for the preparation of optically active compounds.
  • hydrolytic enzymes lipases (lipid-hydrolyzing enzymes) are of great use since they show broad substrate specificity. Lipases are particularly useful in the resolution of racemic alcohols and their esters in organic solvents. However, they often exhibit unsatisfactory enantioselectivity, resulting in a poor resolution. Accordingly, it is highly important to develop new methods for enhancing the lipase enantioselectivity.
  • the object of the present invention is to provide a coated enzyme having better enantioselectivity and reusability compared to its uncoated native counterpart.
  • Another object of the present invention is to provide a method of preparing a coated enzyme having better enantioselectivity and reusability compared to its uncoated native counterpart.
  • Another object of the present invention is to provide a method of preparing an optical isomer using the coated enzyme.
  • an enzyme coated with an ionic liquid herein, an ionic liquid is defined as an organic salt present as a liquid phase at a temperature of around 150°C or below.
  • the present invention also provides a method of preparing an ionic liquid- coated enzyme comprising the steps of: dissolving the ionic liquid suitable for coating the enzyme, at a temperature of its melting point or above; mixing the dissolved ionic liquid with the enzyme; and cooling the mixture at room temperature to solidify the ionic liquid coated on the enzyme.
  • the present invention still further provides a method of preparing an optical isomer having a high Enantiomeric Excess comprising the steps of selectively reacting any one enantiomer of a racemic compound with an ionic liquid-coated enzyme.
  • ionic liquid coated enzyme herein means an organic salt which presents as a solid phase at room temperature, while it typically presents as a liquid phase at its melting temperature of 150 ° C or below.
  • a solid ionic liquid (example: 1-alkyl-3-methylimidazolium hexafluorophosphate) as the enzyme-coating material is synthesized in two steps from 1-methylimidazole.
  • the ionic liquid for coating an enzyme presents as a solid phase at room temperature and turns to a liquid phase upon heating to a temperature of its melting point or above.
  • the ionic liquid thus, presents as a liquid phase at a temperature of 150 ° C or below, and preferably at a temperature of between 120 ° C and 150°C.
  • An organic cation of an ionic liquid may include a cation of a heterocyclic compound, and an organic or inorganic anion forming an ionic bond with the cation thereof.
  • the heterocyclic compound is composed of at least one heteroatom selected from the group consisting of N, O, S, or a combination thereof, and the number of heteroatoms is preferably 1 to 4 and more preferably 1 to 2.
  • the cation of the heterocyclic compound is a cation of a compound selected from the group consisting of imidazolium, pyridinium, pyridazinium, pyrimidinium, pyrazinium, pyrazolium, thiazolium, oxazolium, triazolium, and a substituted compound thereof.
  • the organic or inorganic anion may be any one of bis(perfluoroethyl sulfonyl)imide (N(C 2 F 5 SO2) 2 " ), bis(trifluoromethyl sulfonyl)imide (N(CF 3 SO 2 )2 " ), tris(trifluororaethyl sulfonyl)methide (C(CF 3 SO 2 ) 2 " ) > trifluoromethane sulfonimide, trifluoromethyl sulfonimide, trifluoromethyl sulfonate, AsF 6 " , CIO 4 " , PF 6 “ , and BF 4 " .
  • the ionic liquid according to present invention is preferably represented by the following Formula 1 :
  • X is selected from the group consisting of phenyl, substituted phenyl, methacryloyl ester, OCOCH 3 , CO 2 CH 3 , and CN;
  • Y is BF 4 or PF 6 ; and n is an integer of 2 to 5.
  • the substituted phenyl group is a phenyl group having at least one substituent selected from the group consisting of a C ⁇ -3 alkyl, a d -3 alkoxy, an ester, an amide, hydroxy, cyano, a halogen, and nitro.
  • a method of preparing an ionic liquid-coated enzyme (ILCE) according to the present invention comprises: melting the ionic liquid suitable for coating the enzyme at a temperature of its melting point or above; mixing the melted ionic liquid with the enzyme; and cooling the mixture to solidify the ionic liquid coated on the enzyme. Coating the enzyme according to the present invention is simply achieved by mixing it in the molten ionic liquid and cooling the mixture.
  • the coating of enzyme is initiated by heating the solid ionic liquid up to over its melting point to get its liquid phase, followed by the addition of enzyme powders. The resulting heterogeneous mixture is then allowed to cool down to get a solid solution. Finally, the solid solution is made small particles with a spatula.
  • the small particles as an ILCE are used as the catalysts for the resolution of racemic alcohols.
  • the ILCE exhibits 1.5-2 times better enantioselectivity compared to its uncoated native enzyme.
  • the ionic liquid suitable for coating the enzyme may be obtained commercially or synthesized according to the conventional method known to anyone having ordinary skill in the art.
  • 1-(3-phenylpropyl)-3- methylimidazolium hexafluorophosphate represented by Formula 1 is prepared from the reaction of c with 1-chloro-3-phenylpropane to obtain 1-(3-phenylpropyl)-3- methylimidazolium chloride, and then with HPF 6 to exchange anions.
  • the amount of ionic liquid is varied depending upon the type of enzyme used, but it is preferably between 5 and 20 g per 1 g of enzyme. When the amount of ionic liquid is less than 5g, the coating effect is insufficient. While when the amount is more than 20 g, it is not preferably since the activity per unit weight of coated enzyme is reduced.
  • the enzyme to be coated with the ionic liquid may include, but is not limited to, lipase, which is conveniently used in preparation of an optically active compound.
  • lipase may include Pseudomonas cepacia lipase (LPS), Candida antarctica lipase (CAL), Candida rugosa lipase (CRL), Aspergillus niger lipase (ANL), Candida cylindracea lipase (CCL), Mucor miehei lipase,
  • Pseudomonas fluorecens lipase (LAK), Rhizopus arrhizus lipase, Rhizopus niveus lipase, Hog pancreas lipase, Candida lipolytica lipase, Mucor javanicus lipase, Penicillium roqueforti lipase, and Rhizomucor miehei lipase.
  • an optical isomer having a high enantiomeric excess is prepared by the enantioselective acylation of one enantiomer of a racemic compound.
  • an enantiomer of racemic alcohol is selectively acylated (transesterfication) to obtain chiral esters having good enantiomeric excess.
  • the secondary alcohol may include, but is not limited to, alcohols represented by the following Formulas 2a, 2b, 2c, and 2d:
  • the reaction solvent to be used in the reaction of an ionic liquid-coated enzyme with a racemic compound is preferably, but is not limited to, toluene, ether, or hexane which do not dissolve the ionic liquid, since the yield and enantioselectivity of enzyme-catalyzed reaction is generally not affected by solvent.
  • the amount of reacting solvent is one rendering the reactant to be at a concentration of between 0.2 and 0.4 M.
  • 0.1 mmol of racemic alcohols represented by the following Formulas 2a to 2d, 160-400 mg of 1-methyl-3-(3-phenylpropyl)imidazolium hexafluorophosphate- coated lipase (LPS), and 0.3 mmol of vinyl acetate 0.3mmol were mixed in 0.5 mL of toluene and the mixture was stirred at room temperature.
  • an ionic liquid-coated enzyme is added in an amount of 5.5 to 22 times more than that of a natural enzyme in order to exert the same effect thereof.
  • enantioselectivity of ionic liquid-coated lipase according to Example 3 is better than or equivalent to that of the natural enzyme according to Comparative Example 1.
  • the coated LPS and natural LPS were reused 4 times for the resolution of racemic alcohol having Formula 2b and their activities after each reuse were measured. The results are shown in Table 2.
  • the ionic liquid-coated enzyme according to the present invention remarkably improves enzyme functions, such as enantioselectivity and stability, when the lipase is coated with the ionic liquid. Further, even the case in which the ionic liquid-coated enzyme is reused, the enantiomeric excess, enantioselectivity, and activity are not substantially degenerated.
  • the coated enzyme is usable for a catalyst for providing a chiral intermediate required in the synthesis of chiral pesticides, medicines, natural chemicals, and so on.

Landscapes

  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Zoology (AREA)
  • Engineering & Computer Science (AREA)
  • Wood Science & Technology (AREA)
  • Genetics & Genomics (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Microbiology (AREA)
  • Biotechnology (AREA)
  • Biochemistry (AREA)
  • General Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Biomedical Technology (AREA)
  • Molecular Biology (AREA)
  • Medicinal Chemistry (AREA)
  • Analytical Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Enzymes And Modification Thereof (AREA)

Abstract

Disclosed is an ionic liquid-coated enzyme, wherein the ionic liquid is an organic salt which presents as a liquid phase at a temperature of about 150°C or below. The ionic liquid-coated enzyme according to the present invention remarkably improves enzyme functions, such as enantioselectivity and stability, when the enzyme which may be lipase is coated with an ionic liquid. Further, even in the case of when the ionic liquid-coated enzyme is reused, the enantiomeric excess, enantioselectivity, and activity are not degenerated. The coated enzyme is usable as a catalyst for providing a chiral intermediate required in the synthesis of chiral pesticides, medicines, natural chemicals, and so on.

Description

ENZYMES COATED WITH IONIC LIQUID
BACKGROUND OF THE INVENTION
(a) Field of the Invention
The present invention relates to an enzyme coated with an ionic liquid and more particularly, to the preparation and use of an enzyme coated with an ionic liquid, which shows better enantioselectivity than its uncoated counterpart and can be repeatedly reused with no significant loss in catalytic activities. (b) Description of the Related Art
Enzymatic kinetic resolution of racemic substrates using hydrolytic enzymes provides a useful methodology for the preparation of optically active compounds. Among the hydrolytic enzymes, lipases (lipid-hydrolyzing enzymes) are of great use since they show broad substrate specificity. Lipases are particularly useful in the resolution of racemic alcohols and their esters in organic solvents. However, they often exhibit unsatisfactory enantioselectivity, resulting in a poor resolution. Accordingly, it is highly important to develop new methods for enhancing the lipase enantioselectivity.
Various techniques have been so far developed for solving the enantioselectivity problem, A representative approach is the coating of enzyme with a lipid (Okahata, Y.; Hatano, A.; Ijiro, K. Tetrahedron: Asymmetry 1995, 6, 1311) or a surfactant (Huang, S. Y.; Chang, H. L; Goto, M. Enzyme Microb. Technol., 1998, 22, 552). However, these methods are rather complicated to follow and cause loss in enzyme activities.
SUMMARY OF THE INVENTION
The object of the present invention is to provide a coated enzyme having better enantioselectivity and reusability compared to its uncoated native counterpart.
Another object of the present invention is to provide a method of preparing a coated enzyme having better enantioselectivity and reusability compared to its uncoated native counterpart.
Another object of the present invention is to provide a method of preparing an optical isomer using the coated enzyme.
To active these objects, the present invention provides an enzyme coated with an ionic liquid (herein, an ionic liquid is defined as an organic salt present as a liquid phase at a temperature of around 150°C or below). The present invention also provides a method of preparing an ionic liquid- coated enzyme comprising the steps of: dissolving the ionic liquid suitable for coating the enzyme, at a temperature of its melting point or above; mixing the dissolved ionic liquid with the enzyme; and cooling the mixture at room temperature to solidify the ionic liquid coated on the enzyme.
The present invention still further provides a method of preparing an optical isomer having a high Enantiomeric Excess comprising the steps of selectively reacting any one enantiomer of a racemic compound with an ionic liquid-coated enzyme.
DETAILED DESCRIPTION OF THE PREFERRED EMBODIMENTS
A more complete appreciation of the invention, and many of the attendant advantages thereof, will be readily apparent as the same becomes better understood by reference to the following detailed description. The present invention describes the preparation of an ionic liquid coated enzyme (ILCE) and its use in the kinetic resolution of racemic alcohols. The term "ionic liquid" herein means an organic salt which presents as a solid phase at room temperature, while it typically presents as a liquid phase at its melting temperature of 150°C or below. A solid ionic liquid (example: 1-alkyl-3-methylimidazolium hexafluorophosphate) as the enzyme-coating material is synthesized in two steps from 1-methylimidazole.
Many studies regarding the use of these ionic liquids as the solvents for catalysis (Wasserscheid, P.; Wilhelm, K. Angew. Chem. Int. Ed. 2000, 39, 3772) have showed that ionic liquids have great potential as alternatives to conventional organic solvents because they are environmentally benign due to high boiling points and improve the activity and selectivity of catalysts. Studies on biocatalytic reactions in ionic liquid have also showed various advantages such that the activity and enantioselectivity of enzymes are improved, when compared to a biocatalytic reaction in a conventional organic solvent (Kim, K. W.; Song, B.; Choi, M. Y.; Kim, M. -J. Org. Lett. 2001 , 3, 1507.; Erbeldinger, M.; Mesiano, A. J.; Russell, A. J.
Biotechnol. Prog. 2000, 16, 1131.; Lau, R. M.; Rantwijk, F. van; Seddon, K. R.; Sheldon, R. A. Org. Lett. 2000, 2, 4189.).
The ionic liquid for coating an enzyme presents as a solid phase at room temperature and turns to a liquid phase upon heating to a temperature of its melting point or above. The ionic liquid, thus, presents as a liquid phase at a temperature of 150°C or below, and preferably at a temperature of between 120°C and 150°C. An organic cation of an ionic liquid may include a cation of a heterocyclic compound, and an organic or inorganic anion forming an ionic bond with the cation thereof.
The heterocyclic compound is composed of at least one heteroatom selected from the group consisting of N, O, S, or a combination thereof, and the number of heteroatoms is preferably 1 to 4 and more preferably 1 to 2. The cation of the heterocyclic compound is a cation of a compound selected from the group consisting of imidazolium, pyridinium, pyridazinium, pyrimidinium, pyrazinium, pyrazolium, thiazolium, oxazolium, triazolium, and a substituted compound thereof. The organic or inorganic anion may be any one of bis(perfluoroethyl sulfonyl)imide (N(C2F5SO2)2 "), bis(trifluoromethyl sulfonyl)imide (N(CF3SO2)2"), tris(trifluororaethyl sulfonyl)methide (C(CF3SO2)2 ")> trifluoromethane sulfonimide, trifluoromethyl sulfonimide, trifluoromethyl sulfonate, AsF6 ", CIO4 ", PF6 ", and BF4 ".
The ionic liquid according to present invention is preferably represented by the following Formula 1 :
Formula 1
Figure imgf000004_0001
wherein
X is selected from the group consisting of phenyl, substituted phenyl, methacryloyl ester, OCOCH3, CO2CH3, and CN;
Y is BF4or PF6; and n is an integer of 2 to 5.
The substituted phenyl group is a phenyl group having at least one substituent selected from the group consisting of a Cι-3 alkyl, a d-3 alkoxy, an ester, an amide, hydroxy, cyano, a halogen, and nitro.
A method of preparing an ionic liquid-coated enzyme (ILCE) according to the present invention comprises: melting the ionic liquid suitable for coating the enzyme at a temperature of its melting point or above; mixing the melted ionic liquid with the enzyme; and cooling the mixture to solidify the ionic liquid coated on the enzyme. Coating the enzyme according to the present invention is simply achieved by mixing it in the molten ionic liquid and cooling the mixture.
The coating of enzyme is initiated by heating the solid ionic liquid up to over its melting point to get its liquid phase, followed by the addition of enzyme powders. The resulting heterogeneous mixture is then allowed to cool down to get a solid solution. Finally, the solid solution is made small particles with a spatula. The small particles as an ILCE are used as the catalysts for the resolution of racemic alcohols. The ILCE exhibits 1.5-2 times better enantioselectivity compared to its uncoated native enzyme. The ionic liquid suitable for coating the enzyme may be obtained commercially or synthesized according to the conventional method known to anyone having ordinary skill in the art. For example, 1-(3-phenylpropyl)-3- methylimidazolium hexafluorophosphate represented by Formula 1 is prepared from the reaction of c with 1-chloro-3-phenylpropane to obtain 1-(3-phenylpropyl)-3- methylimidazolium chloride, and then with HPF6 to exchange anions.
The amount of ionic liquid is varied depending upon the type of enzyme used, but it is preferably between 5 and 20 g per 1 g of enzyme. When the amount of ionic liquid is less than 5g, the coating effect is insufficient. While when the amount is more than 20 g, it is not preferably since the activity per unit weight of coated enzyme is reduced.
The enzyme to be coated with the ionic liquid may include, but is not limited to, lipase, which is conveniently used in preparation of an optically active compound. Representative examples of the lipase may include Pseudomonas cepacia lipase (LPS), Candida antarctica lipase (CAL), Candida rugosa lipase (CRL), Aspergillus niger lipase (ANL), Candida cylindracea lipase (CCL), Mucor miehei lipase,
Pseudomonas fluorecens lipase (LAK), Rhizopus arrhizus lipase, Rhizopus niveus lipase, Hog pancreas lipase, Candida lipolytica lipase, Mucor javanicus lipase, Penicillium roqueforti lipase, and Rhizomucor miehei lipase.
Using the ionic liquid-coated enzyme as a catalyst, an optical isomer having a high enantiomeric excess (optical purity) is prepared by the enantioselective acylation of one enantiomer of a racemic compound. For example, using the ionic liquid-coated lipase, an enantiomer of racemic alcohol is selectively acylated (transesterfication) to obtain chiral esters having good enantiomeric excess.
In an optical resolution process of racemic secondary alcohols using a coated lipase, the secondary alcohol may include, but is not limited to, alcohols represented by the following Formulas 2a, 2b, 2c, and 2d:
Figure imgf000006_0001
Figure imgf000006_0002
The reaction solvent to be used in the reaction of an ionic liquid-coated enzyme with a racemic compound is preferably, but is not limited to, toluene, ether, or hexane which do not dissolve the ionic liquid, since the yield and enantioselectivity of enzyme-catalyzed reaction is generally not affected by solvent.
The amount of reacting solvent is one rendering the reactant to be at a concentration of between 0.2 and 0.4 M.
Hereinafter, the present invention will be explained in detail with reference to examples and comparative examples. These examples, however, should not in any sense be interpreted as limiting the scope of the present invention.
Example 1
Preparation of 1-(3-phenylpropyl)-3-methylimidazolium chloride 0.15 mole of 1 -methylimidazole and 0.125 mole of 1-chloro-3- phenylpropane were introduced into a 100 mL round bottom flask and stirred at 70 °C for one day to obtain 1-(3-phenylpropyl)-3-methylimidazolium chloride (yield 99 %).
1H-NMR (CD3CN, δ, 300MHz) 2.18 (m, 2H, CH2), 2.64 (t, 2H, J = 7.4 Hz, CH2), 3.90 (s, 1 H, NCH3), 4.27 (t, 2H, J = 7.1 Hz, CH2), 7.18-7.30 (m, 5H, C6H5), 7.56 (s, 1 H, CH), 7.63 (s, 1 H, CH), 9.94 (s, 1 H, CH).
Preparation of 1-(3-phenylpropyl)-3-methylimidazolium hexafluorophosphate
1.2 equivalents of HPF6 were slowly added to 1-(3-phenylpropyl)-3- methylimidazolium chloride under ice cooling. After stirring for 30 minutes, the mixture was extracted with methylene chloride (MC) three times. The extract was dried over anhydrous sodium sulfate and concentrated to obtain 1-(3-phenylpropyl)- 3-methylimidazolium hexafluorophosphate (mp 52-53 °C , yield 78%).
1H-NMR (CD3CN, δ, 300MHz) 2.14 (m, 2H, CH2), 2.65 (t, 2H, J = 7.4 Hz, CH2), 3.80 (s, 1 H, NCH3), 4.14 (t, 2H, J = 7.2 Hz, CH2), 7.19-7.35 (m, 7H), δ8.34 (s, 1 H, CH).
Example 2
Coating on lipase with 1-methyl-3-(3-phenylpropyl) imidazolium hexafluorophosphate To the molten 1 g of 1-methyl-3-(3-phenylpropyl)imidazolium hexafluorophosphate at a temperature of its melting point or above, 100 mg of lipase (LPS, lipase from Pseudomonas cepacia) was added. After stirring for 10 minutes, the resulting mixture was cooled to room temperature to obtain 1.1 g of coated lipase.
Example 3 Optical Resolution of Racemic Alcohols with the Coated Lipase (LPS)
0.1 mmol of racemic alcohols represented by the following Formulas 2a to 2d, 160-400 mg of 1-methyl-3-(3-phenylpropyl)imidazolium hexafluorophosphate- coated lipase (LPS), and 0.3 mmol of vinyl acetate 0.3mmol were mixed in 0.5 mL of toluene and the mixture was stirred at room temperature. Generally, an ionic liquid-coated enzyme is added in an amount of 5.5 to 22 times more than that of a natural enzyme in order to exert the same effect thereof.
Figure imgf000007_0001
Figure imgf000007_0002
The reaction was terminated when thin layer chromatography confirmed that the acylation had proceeded to around 50%. Lipase (LPS) was filtered from the reaction mixture and the solvent was evaporated. Then, the enantiomeric excesses of chiral acetate and non-acylated alcohol were measured by high performance liquid chromatography equipped with chiral column.
Comparative Example 1
Optical Resolution of Racemic Alcohols bv Natural Lipase (LPS^ The same method as in Example 3 was performed, except that 16-36 mg of natural lipase was used instead of the coated lipase (LPS).
The optical purities of chiral ester and remained racemic alcohols prepared according to Example 3 and Comparative Example 1 are shown in Table 1. Table 1
Figure imgf000008_0001
note) Enantiomeric Excess (ee) = (R-S)/(R+S)
As shown in Table 1 , enantioselectivity of ionic liquid-coated lipase according to Example 3 is better than or equivalent to that of the natural enzyme according to Comparative Example 1.
Example 4
Activity of the Reused Natural LPS or the Reused Coated LPS
The coated LPS and natural LPS were reused 4 times for the resolution of racemic alcohol having Formula 2b and their activities after each reuse were measured. The results are shown in Table 2.
Table 2
Figure imgf000008_0002
Figure imgf000009_0001
note) Enantiomeric Excess (ee) = (R-S)/(R+S)
As shown in Table 2, the activity was dramatically degenerated when the natural LPS (Comparative Example 1) was reused, while the activity and enantioselectivity were not substantially reduced when the ionic liquid-coated LPS (Example 3) was reused even after four times.
The ionic liquid-coated enzyme according to the present invention remarkably improves enzyme functions, such as enantioselectivity and stability, when the lipase is coated with the ionic liquid. Further, even the case in which the ionic liquid-coated enzyme is reused, the enantiomeric excess, enantioselectivity, and activity are not substantially degenerated. The coated enzyme is usable for a catalyst for providing a chiral intermediate required in the synthesis of chiral pesticides, medicines, natural chemicals, and so on. While the present invention has been described in detail with reference to the preferred embodiments, those skilled in the art will appreciate that various modifications and substitutions can be made thereto without departing from the spirit and scope of the present invention as set forth in the appended claims.

Claims

WHAT IS CLAIMED IS:
1. An enzyme coated with an ionic liquid, wherein the ionic liquid is an organic salt which presents at a temperature of about 150 °C or below.
2. The ionic liquid-coated enzyme according to Claim 1 , wherein the ionic liquid comprises an organic cation of a heterocyclic compound and an organic or inorganic anion.
3. The ionic liquid-coated enzyme according to Claim 2, wherein the organic cation of the heterocyclic compound comprises 1 ~4 heteroatoms selected from the group consisting of N, O, S, or a combination thereof.
4. The ionic liquid-coated enzyme according to Claim 3, wherein the organic cation of the heterocyclic compound is selected from the group consisting of imidazolium, pyridinium, pyridazinium, pyrimidinium, pyrazinium, pyrazolium, thiazolium, oxazolium, and triazolium, or an cation of a substituted compound thereof.
5. The ionic liquid-coated enzyme according to Claim 2, wherein the organic or inorganic anion is selected from the group consisting of bis(perfluoroethyl sulfonyl)imide (N(C2F5SO2)2~)> bis(trifluoromethyl sulfonyl)imide (N(CF3SO2)2")> tris(trifluoromethyl sulfonyl methide (C(CF3SO2)2 "), trifluoromethane sulfone imide, trifluoromethyl sulfone imide, trifluoromethyl sulfonate, AsF6 ", CIO ", PF6 ", and BF4 ".
6. The ionic liquid-coated enzyme according to Claim 1 , wherein the ionic liquid is represented by the following Formula 1 : Formula 1
Figure imgf000010_0001
wherein X is selected from the group consisting of phenyl, substituted phenyl, methacryloyl ester, OCOCH3, CO2CH3, and CN; Y is BF4or PF6; and N is an integer of 2 to 5.
7. The ionic liquid-coated enzyme according to Claim 1 , wherein the enzyme is lipase.
8. The ionic liquid-coated enzyme according to Claim 7, wherein the lipase is selected from the group consisting of Pseudomonas cepacia lipase (LPS), Candida antarctica lipase (CAL), Candida rugosa lipase (CRL), Aspergillus niger lipase (ANL), Candida cylindracea lipase (CCL), Mucor miehei lipase, Pseudomonas fluorecens lipase (LAK), Rhizopus arrhizus lipase, Rhizopus niveus lipase, Hog pancreas lipase, Candida lipolytica lipase, Mucor javanicus lipase, Penicillium roqueforti lipase, and Rhizomucor miehei lipase.
9. A method of preparing an ionic liquid-coated enzyme comprising the steps of: melting an ionic liquid suitable for coating the enzyme, at a temperature of its melting point or above, wherein the ionic liquid is an organic salt which presents as a liquid phase at a temperature of about 150°C or below; mixing the melted ionic liquid with the enzyme; and cooling the mixture to solidify the ionic liquid coated on the enzyme.
10. The method according to Claim 9, wherein the ionic liquid is represented by the following Formula 1 :
Formula 1
Figure imgf000011_0001
wherein X is selected from the group consisting of phenyl, substituted phenyl, methacryloyl ester, OCOCH3, CO2CH3, and CN; Y is BF4or PF6; and N is an integer of 2 to 5.
11. A method of preparing an optical isomer having a high enantiomeric excess comprising the steps of selectively reacting any one enantiomer of a racemic compound with the ionic liquid-coated enzyme according to Claim 1.
PCT/KR2003/000067 2002-01-14 2003-01-13 Enzymes coated with ionic liquid WO2003057871A1 (en)

Priority Applications (4)

Application Number Priority Date Filing Date Title
JP2003558171A JP2005514033A (en) 2002-01-14 2003-01-13 Enzyme coated with ionic liquid, method for producing the same, and method for producing optical isomers
US10/471,190 US7005282B2 (en) 2002-01-14 2003-01-13 Enzymes coated with ionic liquid
EP03701172A EP1468083A1 (en) 2002-01-14 2003-01-13 Enzymes coated with ionic liquid
CA002441430A CA2441430A1 (en) 2002-01-14 2003-01-13 Enzymes coated with ionic liquid

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
KR10-2002-0002056A KR100485090B1 (en) 2002-01-14 2002-01-14 Enzymes coated with ionic liquid
KR10-2002-0002056 2002-01-14

Publications (1)

Publication Number Publication Date
WO2003057871A1 true WO2003057871A1 (en) 2003-07-17

Family

ID=19718448

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/KR2003/000067 WO2003057871A1 (en) 2002-01-14 2003-01-13 Enzymes coated with ionic liquid

Country Status (7)

Country Link
US (1) US7005282B2 (en)
EP (1) EP1468083A1 (en)
JP (1) JP2005514033A (en)
KR (1) KR100485090B1 (en)
CN (1) CN1498268A (en)
CA (1) CA2441430A1 (en)
WO (1) WO2003057871A1 (en)

Cited By (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2008519106A (en) * 2004-11-01 2008-06-05 ザ プロクター アンド ギャンブル カンパニー Delivery system for beneficial agents containing ionic liquids
US7928053B2 (en) 2004-11-01 2011-04-19 The Procter & Gamble Company Multiphase cleaning compositions having ionic liquid phase
WO2013008172A1 (en) * 2011-07-12 2013-01-17 Ecole D'ingenieurs Et D'architectes De Fribourg Zwitterionic liquid as co-catalyst for the enzymatic esterification

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP5142178B2 (en) * 2006-03-10 2013-02-13 独立行政法人科学技術振興機構 Immobilized Lewis acid catalyst coated with ionic liquid and use thereof
JP2010111599A (en) * 2008-11-04 2010-05-20 Mazda Motor Corp Ionic liquid and manufacturing method of the same, and power storage apparatus using the ionic liquid
KR100974612B1 (en) * 2009-10-13 2010-08-06 (유)동양건업 Cutting machine for road
CN109752356B (en) * 2018-11-27 2021-02-26 河南师范大学 Method for rapidly and visually screening ionic liquid catalyst
KR20210079030A (en) 2019-12-19 2021-06-29 엘지전자 주식회사 Compressor

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1435905A (en) * 1972-11-03 1976-05-19 Unilever Ltd Enzyme granules
IL129086A0 (en) * 1999-03-22 2000-02-17 Enzymotec Ltd Surfactant-lipase complex immobilized on insoluble matrix

Non-Patent Citations (4)

* Cited by examiner, † Cited by third party
Title
BIOTECHNOLOGY AND BIOENGINEERING, vol. 76, no. 2, 2001, pages 157 - 163 *
DATABASE CA [online] MORI T. ET AL.: "A lipid-coated lipase as an efficient hydrolytic catalyst in two-phase aqueous-organic system", XP002978865, accession no. STN Database accession no. 135:356800 *
DATABASE CA [online] OKAHATA Y. ET AL.: "Enzyme-lipid complex. 9. Enhancing enantioselectivity of a lipid-coated lipase via imprinting methods for esterification in organic solvents", XP002978864, accession no. STN Database accession no. 123:138032 *
TETRAHEDRON: ASYMMETRY, vol. 6, no. 6, 1995, pages 1311 - 1322 *

Cited By (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2008519106A (en) * 2004-11-01 2008-06-05 ザ プロクター アンド ギャンブル カンパニー Delivery system for beneficial agents containing ionic liquids
US7928053B2 (en) 2004-11-01 2011-04-19 The Procter & Gamble Company Multiphase cleaning compositions having ionic liquid phase
US7939485B2 (en) 2004-11-01 2011-05-10 The Procter & Gamble Company Benefit agent delivery system comprising ionic liquid
JP4824028B2 (en) * 2004-11-01 2011-11-24 ザ プロクター アンド ギャンブル カンパニー Delivery system for beneficial agents containing ionic liquids
WO2013008172A1 (en) * 2011-07-12 2013-01-17 Ecole D'ingenieurs Et D'architectes De Fribourg Zwitterionic liquid as co-catalyst for the enzymatic esterification

Also Published As

Publication number Publication date
CN1498268A (en) 2004-05-19
CA2441430A1 (en) 2003-07-17
KR20030061527A (en) 2003-07-22
EP1468083A1 (en) 2004-10-20
JP2005514033A (en) 2005-05-19
KR100485090B1 (en) 2005-04-22
US20040087462A1 (en) 2004-05-06
US7005282B2 (en) 2006-02-28

Similar Documents

Publication Publication Date Title
Itoh et al. Increased Enantioselectivity and Remarkable Acceleration of Lipase‐Catalyzed Transesterification by Using an Imidazolium PEG–Alkyl Sulfate Ionic Liquid
CA1253098A (en) Method of making chiral epoxy alcohols
Kazlauskas Elucidating structure-mechanism relationships in lipases: prospects for predicting and engineering catalytic properties
EP3625236B1 (en) A process for preparing an optically active cineole derivative
US7005282B2 (en) Enzymes coated with ionic liquid
Fazlena et al. Dynamic kinetic resolution: alternative approach in optimizing S-ibuprofen production
Cao et al. Biocatalysis in organic solvents, supercritical fluids and ionic liquids
Haak et al. Synthesis of enantiopure chloroalcohols by enzymatic kinetic resolution
Koszelewski et al. Enzyme promiscuity as a remedy for the common problems with Knoevenagel condensation
Lou et al. Markedly improving lipase-mediated asymmetric ammonolysis of D, Lp-hydroxyphenylglycine methyl ester by using an ionic liquid as the reaction medium
Jin et al. Enzymatic production of enantiopure ketoprofen in a solvent-free two-phase system
Wang et al. Kinetic resolution of (R, S)-pyrazolides containing substituents in the leaving pyrazole for increased lipase enantioselectivity
Nishizawa et al. Studies on hydrolysis of chiral, achiral and racemic alcohol esters withPseudomonas cepacia lipase: mechanism of stereospecificity ofthe enzyme
Brady et al. Optimisation of the enantioselective biocatalytic hydrolysis of naproxen ethyl ester using ChiroCLEC-CR
Okamoto et al. Drastic enhancement of the enantioselectivity of lipase-catalysed esterification in organic solvents by the addition of metal ions
Pan et al. Effect of alcohol chain length on the enzymatic resolution of racemic mandelic acid and kinetic study
Zheng et al. Enhancement of enantioselectivity in lipase-catalyzed resolution of N-(2-ethyl-6-methylphenyl) alanine by additives
Paul et al. Biocatalysis and biotransformation in ionic liquids
IL92122A (en) Process for preparing optically active glycidate esters
Yuan et al. Lipase-catalyzed hydrolysis of 2-(4-hydroxyphenyl) propionic acid ethyl ester to (R)-(−)-2-(4-hydroxyphenyl) propanoic acid
JP2003533993A (en) Process for producing enantiomer-rich esters and alcohols
Kao et al. (R, S)‐2‐chlorophenoxyl pyrazolides as novel substrates for improving lipase‐catalyzed hydrolytic resolution
Okamoto et al. A new method for improving the enantioselectivity of lipase-catalyzed hydrolysis in organic solvent containing a small amount of water in the presence of metal ions
WO2005014509A1 (en) Process for the preparation of enantiomerically enriched esters and alcohols
Takaç et al. A parametric study on biphasic medium conditions for the enantioselective production of naproxen by Candida rugosa lipase

Legal Events

Date Code Title Description
AK Designated states

Kind code of ref document: A1

Designated state(s): CA CN IN JP US

AL Designated countries for regional patents

Kind code of ref document: A1

Designated state(s): AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HU IE IT LU MC NL PT SE SI SK TR

121 Ep: the epo has been informed by wipo that ep was designated in this application
WWE Wipo information: entry into national phase

Ref document number: 10471190

Country of ref document: US

WWE Wipo information: entry into national phase

Ref document number: 2441430

Country of ref document: CA

WWE Wipo information: entry into national phase

Ref document number: 2003701172

Country of ref document: EP

WWE Wipo information: entry into national phase

Ref document number: 1535/DELNP/2003

Country of ref document: IN

WWE Wipo information: entry into national phase

Ref document number: 038001152

Country of ref document: CN

WWE Wipo information: entry into national phase

Ref document number: 2003558171

Country of ref document: JP

WWP Wipo information: published in national office

Ref document number: 2003701172

Country of ref document: EP

WWW Wipo information: withdrawn in national office

Ref document number: 2003701172

Country of ref document: EP